Hua A Jenny Lu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aquaporin 2 | 21 | 2023 | 148 | 5.620 |
Why?
|
| Kidney Tubules, Collecting | 7 | 2020 | 178 | 2.680 |
Why?
|
| Diabetes Insipidus | 2 | 2023 | 151 | 1.380 |
Why?
|
| Polyuria | 2 | 2017 | 39 | 1.220 |
Why?
|
| Vasopressins | 10 | 2017 | 370 | 1.210 |
Why?
|
| Endocytosis | 10 | 2017 | 985 | 1.080 |
Why?
|
| Exocytosis | 9 | 2017 | 354 | 1.030 |
Why?
|
| Kidney Glomerulus | 2 | 2017 | 697 | 0.990 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 2 | 2023 | 23 | 0.970 |
Why?
|
| Receptors, Vasopressin | 3 | 2023 | 112 | 0.850 |
Why?
|
| Aquaporins | 1 | 2023 | 174 | 0.830 |
Why?
|
| Cytoskeletal Proteins | 2 | 2017 | 1364 | 0.800 |
Why?
|
| Kidney Concentrating Ability | 2 | 2017 | 41 | 0.750 |
Why?
|
| Kidney | 10 | 2023 | 7184 | 0.740 |
Why?
|
| Water | 5 | 2023 | 1395 | 0.710 |
Why?
|
| Gentamicins | 1 | 2020 | 255 | 0.690 |
Why?
|
| Protein Transport | 10 | 2017 | 1988 | 0.630 |
Why?
|
| Cell Membrane | 9 | 2017 | 3749 | 0.610 |
Why?
|
| Kidney Medulla | 1 | 2017 | 182 | 0.580 |
Why?
|
| Collagen Type IV | 1 | 2017 | 140 | 0.580 |
Why?
|
| Enalapril | 1 | 2018 | 327 | 0.570 |
Why?
|
| Ureteral Obstruction | 1 | 2018 | 296 | 0.570 |
Why?
|
| Podocytes | 3 | 2017 | 396 | 0.560 |
Why?
|
| LLC-PK1 Cells | 6 | 2017 | 132 | 0.540 |
Why?
|
| Glomerulonephritis | 1 | 2017 | 372 | 0.520 |
Why?
|
| Water-Electrolyte Balance | 2 | 2017 | 346 | 0.510 |
Why?
|
| Chlorides | 1 | 2017 | 667 | 0.500 |
Why?
|
| Epithelial Cells | 5 | 2015 | 3690 | 0.480 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2017 | 293 | 0.480 |
Why?
|
| Phosphorylation | 9 | 2017 | 8437 | 0.460 |
Why?
|
| Autoantigens | 1 | 2017 | 892 | 0.440 |
Why?
|
| trans-Golgi Network | 1 | 2012 | 33 | 0.420 |
Why?
|
| Acid-Base Equilibrium | 2 | 2012 | 185 | 0.410 |
Why?
|
| HSC70 Heat-Shock Proteins | 2 | 2012 | 52 | 0.410 |
Why?
|
| Cytoskeleton | 1 | 2016 | 1185 | 0.400 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 804 | 0.390 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1223 | 0.390 |
Why?
|
| Serine | 2 | 2012 | 826 | 0.380 |
Why?
|
| Actins | 1 | 2017 | 2121 | 0.350 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1741 | 0.350 |
Why?
|
| Gene Deletion | 1 | 2017 | 2751 | 0.340 |
Why?
|
| Swine | 8 | 2017 | 5918 | 0.330 |
Why?
|
| Morphogenesis | 1 | 2012 | 752 | 0.320 |
Why?
|
| Simvastatin | 1 | 2011 | 360 | 0.320 |
Why?
|
| Dogs | 5 | 2017 | 3912 | 0.310 |
Why?
|
| Phosphoserine | 1 | 2008 | 206 | 0.310 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 1968 | 0.300 |
Why?
|
| Humeral Fractures | 1 | 2010 | 272 | 0.300 |
Why?
|
| Animals | 28 | 2023 | 168770 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2918 | 0.290 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2148 | 0.270 |
Why?
|
| Microscopy, Confocal | 3 | 2017 | 1970 | 0.260 |
Why?
|
| Clathrin | 3 | 2017 | 267 | 0.250 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2200 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5749 | 0.240 |
Why?
|
| Regeneration | 1 | 2013 | 1485 | 0.240 |
Why?
|
| Fracture Fixation, Internal | 1 | 2010 | 917 | 0.230 |
Why?
|
| Cyclic AMP | 4 | 2017 | 1472 | 0.220 |
Why?
|
| Joint Instability | 1 | 2010 | 792 | 0.220 |
Why?
|
| Zebrafish | 1 | 2013 | 2996 | 0.200 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10484 | 0.200 |
Why?
|
| Fibrosis | 2 | 2018 | 2029 | 0.190 |
Why?
|
| Apoptosis | 2 | 2017 | 9726 | 0.190 |
Why?
|
| Cell Movement | 1 | 2012 | 5218 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 2007 | 0.180 |
Why?
|
| Rats, Brattleboro | 4 | 2014 | 41 | 0.180 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 143 | 0.170 |
Why?
|
| Rats | 10 | 2017 | 24252 | 0.170 |
Why?
|
| Antidiuretic Agents | 2 | 2017 | 24 | 0.170 |
Why?
|
| Cell Line | 6 | 2016 | 16000 | 0.170 |
Why?
|
| Models, Animal | 4 | 2013 | 2173 | 0.170 |
Why?
|
| Manganese Compounds | 1 | 2017 | 27 | 0.160 |
Why?
|
| Mice, Knockout | 4 | 2017 | 14561 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 21833 | 0.150 |
Why?
|
| Helium | 1 | 2017 | 123 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2017 | 156 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2017 | 3001 | 0.150 |
Why?
|
| Polymerization | 1 | 2017 | 164 | 0.150 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2017 | 91 | 0.140 |
Why?
|
| Failure to Thrive | 1 | 2017 | 137 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 241 | 0.140 |
Why?
|
| Lasers, Gas | 1 | 2017 | 93 | 0.140 |
Why?
|
| Mice | 8 | 2020 | 81202 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 314 | 0.140 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2017 | 215 | 0.130 |
Why?
|
| Cardiomegaly | 1 | 2018 | 620 | 0.130 |
Why?
|
| Imidazoles | 2 | 2020 | 1206 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18034 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 906 | 0.120 |
Why?
|
| Integrases | 1 | 2017 | 533 | 0.120 |
Why?
|
| Endothelium | 1 | 2017 | 778 | 0.120 |
Why?
|
| Tyrphostins | 1 | 2014 | 67 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1865 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5868 | 0.120 |
Why?
|
| Nitroreductases | 1 | 2013 | 4 | 0.120 |
Why?
|
| Organ Size | 1 | 2018 | 2251 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1656 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2020 | 19233 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2013 | 263 | 0.100 |
Why?
|
| Signal Transduction | 5 | 2018 | 23406 | 0.100 |
Why?
|
| Metronidazole | 1 | 2013 | 217 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1730 | 0.100 |
Why?
|
| Indoles | 1 | 2020 | 1839 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1516 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2018 | 4222 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 491 | 0.100 |
Why?
|
| Prodrugs | 1 | 2013 | 268 | 0.100 |
Why?
|
| Permeability | 1 | 2013 | 738 | 0.100 |
Why?
|
| Protein Binding | 2 | 2017 | 9384 | 0.090 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 590 | 0.090 |
Why?
|
| Luminescent Proteins | 2 | 2014 | 853 | 0.090 |
Why?
|
| Aquaporin 1 | 1 | 2009 | 58 | 0.090 |
Why?
|
| Hypertonic Solutions | 1 | 2009 | 93 | 0.090 |
Why?
|
| Intra-Articular Fractures | 1 | 2010 | 68 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2012 | 404 | 0.090 |
Why?
|
| Calcitonin | 1 | 2010 | 336 | 0.090 |
Why?
|
| Urine | 1 | 2010 | 370 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2010 | 623 | 0.080 |
Why?
|
| Secretory Pathway | 1 | 2008 | 52 | 0.080 |
Why?
|
| Mutation | 4 | 2023 | 29786 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2012 | 772 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2014 | 8300 | 0.080 |
Why?
|
| beta-Cyclodextrins | 1 | 2008 | 64 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 944 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1549 | 0.080 |
Why?
|
| Transfection | 2 | 2014 | 5895 | 0.080 |
Why?
|
| Ligaments, Articular | 1 | 2010 | 299 | 0.080 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2009 | 416 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 2088 | 0.070 |
Why?
|
| Cell-Free System | 1 | 2007 | 344 | 0.070 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 410 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2012 | 1189 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.070 |
Why?
|
| Microtubules | 1 | 2012 | 1089 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 1005 | 0.070 |
Why?
|
| Elbow Joint | 1 | 2010 | 357 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 464 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 405 | 0.070 |
Why?
|
| Angiotensin II | 1 | 2009 | 881 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3817 | 0.070 |
Why?
|
| Transferrin | 1 | 2007 | 295 | 0.070 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2007 | 195 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2166 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2017 | 3486 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 3773 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 1578 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2018 | 8551 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2969 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2916 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 2014 | 683 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1525 | 0.050 |
Why?
|
| Homeostasis | 1 | 2012 | 3339 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 2027 | 0.050 |
Why?
|
| Reoperation | 1 | 2010 | 4201 | 0.050 |
Why?
|
| Male | 8 | 2018 | 350118 | 0.050 |
Why?
|
| Age Factors | 1 | 2017 | 18373 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 12073 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2010 | 2926 | 0.040 |
Why?
|
| Phenotype | 1 | 2017 | 16367 | 0.040 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8479 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 2700 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 13814 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7882 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17445 | 0.030 |
Why?
|
| Humans | 7 | 2017 | 744376 | 0.030 |
Why?
|
| Rats, Inbred BB | 1 | 2013 | 31 | 0.030 |
Why?
|
| Caveolin 2 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2013 | 387 | 0.030 |
Why?
|
| Loop of Henle | 1 | 2009 | 40 | 0.020 |
Why?
|
| Diuresis | 1 | 2009 | 116 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2012 | 645 | 0.020 |
Why?
|
| Fluorometry | 1 | 2008 | 106 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39052 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2008 | 349 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2008 | 151 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 898 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15295 | 0.020 |
Why?
|
| Losartan | 1 | 2009 | 299 | 0.020 |
Why?
|
| Acetazolamide | 1 | 2007 | 100 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2009 | 625 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2008 | 405 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2008 | 409 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 480 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 489 | 0.020 |
Why?
|
| Time Factors | 3 | 2014 | 40077 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2009 | 451 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 1797 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 697 | 0.020 |
Why?
|
| Cytosol | 1 | 2008 | 901 | 0.020 |
Why?
|
| Diuretics | 1 | 2007 | 591 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2505 | 0.010 |
Why?
|
| Tetrazoles | 1 | 2009 | 835 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 56434 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 63115 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2007 | 1728 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1312 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 3854 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5181 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 213388 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 7798 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11366 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 13035 | 0.010 |
Why?
|
| Female | 1 | 2010 | 380200 | 0.010 |
Why?
|